Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2020C550 Product name: Indacaterolacetaat of indacaterolxinafoaat in combinatie met mometasoonfuroaat, bij voorkeur indacaterolacetaat in combinatie met mometasoonfuroaat

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
2020C/550
Type:
Certificate
SPC type:
Medical
Basic patent number:
078198991
Status:
Open & Published
Publication number:
2020C550
1rst applicant's nationality:
Procedural language:
Dutch

Marketing authorization

Marketing authorization number:
EU/1/20/1439; EU/1/20/1441
Marketing authorization type:
National/EU
Designates country:
No
Marketing authorization date:
02/06/2020
Marketing authorization status:
Accepted
Marketing authorization country:
Belgium (BE)

Dates

Filing date:
25/11/2020
First marketing authorization date:
02/06/2020
Grant date:
Activation date:
BE Publication date:
26/11/2020
Lapsed date:
Expiration date (if granted and all annual fees paid):
Basic SPC Expiration (if granted and all annual fees paid):
02/07/2032
SPC/SPC Extension Expiration (if granted and all annual fees paid):
02/07/2032
Rejection date:
Withdrawal date:

Applicant

Name:
NOVARTIS AG
Legal Form:
AG
From:
26/11/2020
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)
To:

Agent

Name:
DE CLERCQ & PARTNERS CV
Legal Form:
From:
26/11/2020
Address:
Ed. Gevaertdreef 10a, 9830, ST MARTENS LATEM, Belgium (BE)
To:

Publication

Bulletin

Bulletin heading:
SPC
Journal edition number:
2020/28
Publication date:
15/01/2021
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

Annual fee

Annual fee(s) Due Date:
02/08/2027
Annual fee number:
21
Annual fee amount:
650 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type
25/11/2020 General Document Other 3 PDF /6/5/1/8/6/0722068156/docs/2020c550_0_generaldocument_20201126_084611432.pdf
25/11/2020 General Document Other 17 PDF /6/5/1/8/6/0722068156/docs/2020c550_1_generaldocument_20201126_084613840.pdf
25/11/2020 General Document Other 1 PDF /6/5/1/8/6/0722068156/docs/2020c550_2_generaldocument_20201126_084609841.pdf
25/11/2020 Marketing Authorization 1st Marketing Authorization (EU) 3 PDF /6/5/1/8/6/0722068156/docs/2020c550_3_marketingauthorization_20201126_084613524.pdf
07/08/2025 Request For Change Letter of regularisation of a change 1 PDF /6/5/1/8/6/0722068156/docs/2020c550_4_rfc_20250915_114250739.pdf
07/08/2025 Request For Change Letter and/or Form requesting a change in the Register 2 PDF /6/5/1/8/6/0722068156/docs/2020c550_5_rfc_20250915_113619697.pdf
15/09/2025 Outgoing Correspondence Outgoing Correspondence 1 PDF /6/5/1/8/6/0722068156/docs/2020c550_6_221547_pie.rfc.man.notif.pdf
25/11/2020 Marketing Authorization 1st Marketing Authorization (MS) 7 PDF /6/5/1/8/6/0722068156/docs/2020c550_7_marketingauthorization_20201126_084608862.pdf
26/11/2020 Outgoing Correspondence 2 PDF /6/5/1/8/6/0722068156/docs/2020c550_8_outgoingcorrespondence_20201202_035928388.pdf
26/11/2020 Publication I1 1 PDF /6/5/1/8/6/0722068156/docs/2020c550_9_i1document_20201126_113052967.pdf
25/11/2020 Application Form 4 PDF /6/5/1/8/6/0722068156/docs/2020c550_10_applicationform_20201126_084615420.pdf
25/11/2020 Abstract Product Characteristics Abstract of the characteristics of the product 69 PDF /6/5/1/8/6/0722068156/docs/2020c550_11_abstractproductcharacteristics_20201126_084612634.pdf
25/11/2020 General Document Other 4 PDF /6/5/1/8/6/0722068156/docs/2020c550_12_generaldocument_20201126_084608113.pdf
25/11/2020 General Document Other 66 PDF /6/5/1/8/6/0722068156/docs/2020c550_13_generaldocument_20201126_084610608.pdf
13/05/2025 Incoming Correspondence (Email) Cover letter 1 PDF /6/5/1/8/6/0722068156/docs/2020c550_14_incomingcorrespondenceelectronic_20250514_084513627.pdf
13/05/2025 Application Form 3 PDF /6/5/1/8/6/0722068156/docs/2020c550_15_applicationform_20250514_084513846.pdf
13/05/2025 Outgoing Correspondence 2 PDF /6/5/1/8/6/0722068156/docs/2020c550_16_outgoingcorrespondence_20250514_084513488.pdf